The International Clearinghouse for Birth Defects Monitoring Systems: Conjoined twins – an epidemiological study based on 312 cases. Acta Genet Med Gemellol (Roma). 1991, 40: 325-335.
Shaw GM, Jensvold NG, Wasserman CR, Lammer EJ: Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983–1987. Teratology. 1994, 49: 143-149. 10.1002/tera.1420490210.
MRC Vitamin Study Research Group: Prevention of neural tube defects: results of the MRC vitamin study. Lancet. 1991, 338: 131-137. 10.1016/0140-6736(91)90133-A.
Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, et al: Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999, 341: 1485-1490. 10.1056/NEJM199911113412001.
Bower C, Stanley FJ: Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust. 1989, 150: 613-619.
Czeizel AE, Dudas I: Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992, 327: 1832-1835.
Czeizel AE, Dobó M, Vargha P: Hungarian cohort-controlled trial of periconceptional supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res Part A. 2004, 70: 853-861. 10.1002/bdra.20086.
Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, Sever LE, Miller LA, Meaney FJ, Levitt M: Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology. 2002, 66: 33-39. 10.1002/tera.10060.
Canfield MA, Collins JS, Botto LD, Williams LJ, Mai CT, Kirby RS, Pearson K, Devine O, Mulinare J: Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol. 2005, 73: 679-689. 10.1002/bdra.20210.
Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY: Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001, 285: 2981-2986. 10.1001/jama.285.23.2981.
Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA: Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol. 2001, 153: 961-968. 10.1093/aje/153.10.961.
Shaw GM, Velie EM, Schaffer D: Is dietary intake of methionine associated with a reduction in the risk for neural tube defects affected pregnancies. Teratology. 1997, 56: 295-299. 10.1002/(SICI)1096-9926(199711)56:5<295::AID-TERA1>3.0.CO;2-X.
Velie EM, Block G, Shaw GM, Samuels SJ, Schaffer DM, Kulldorff M: Maternal supplemental and dietary zinc intake and the occurrence of neural tube defects in California. Am J Epidemiol. 1999, 150: 605-616.
Schorah CJ, Wild J, Hartley R, Sheppard S, Smithells RW: The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defect. Br J Nutr. 1983, 49: 203-211. 10.1079/BJN19830026.
Shaw GM, Carmichael SL, Yang W, Selvin S, Schaffer DM: Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol. 2004, 160: 102-109. 10.1093/aje/kwh187.
Van den Veyver IB: Genetic effects of methylation diets. Annu Rev Nutr. 2002, 22: 255-282. 10.1146/annurev.nutr.22.010402.102932.
Zeisel SH: Choline: an essential nutrient for humans. Nutrition. 2000, 16: 669-671. 10.1016/S0899-9007(00)00349-X.
Shronts EP: Essential nature of choline with implications for total parenteral nutrition. J Am Diet Assoc. 1997, 97: 639-646. 10.1016/S0002-8223(97)00161-2. 649, quiz 647–648.
Ishidate K: Choline/ethanolamine kinase from mammalian tissues. Biochim Biophys Acta. 1997, 1348: 70-78.
Kent C: CTP:phosphocholine cytidylyltransferase. Biochim Biophys Acta. 1997, 1348: 90.
McMaster CR, Bell RM: CDP-choline:1,2-diacylglycerol cholinephosphotransferase. Biochim Biophys Acta. 1997, 1348: 100-110.
Exton JH: Signaling through phosphatidylcholine breakdown. J Biol Chem. 1990, 265: 1-4.
Zeisel SH, Blusztajn JK: Choline and human nutrition. Annu Rev Nutr. 1994, 14: 269-296. 10.1146/annurev.nu.14.070194.001413.
Fisher MC, Zeisel SH, Mar MH, Sadler TW: Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos. Teratology. 2001, 64: 114-122. 10.1002/tera.1053.
Lykidis A, Murti KG, Jackowski S: Cloning and characterization of a second human CTP:phosphocholine cytidylyltransferase. J Biol Chem. 1998, 273: 14022-14029. 10.1074/jbc.273.22.14022.
Lykidis A, Baburina I, Jackowski S: Distribution of CTP:phosphocholine cytidylyltransferase (CCT) isoforms. Identification of a new CCTbeta splice variant. J Biol Chem. 1999, 274: 26992-27001. 10.1074/jbc.274.38.26992.
Croen LA, Shaw GM, Jensvold NG, Harris JA: Birth defects monitoring in California: a resource for epidemiological research. Paediatr Perinat Epidemiol. 1991, 5: 423-427.